Priorities and challenges for hepatitis B control in the Philippines and the importance of a vaccine dose at birth

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 40, Issue 5, 2009, Pages 972-990

  Ruff, Tilman A ^a   Bravo, Lulu ^b   Gatchalian, Salvacion R ^b,c   Bock, Hans L ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^c GLAXOSMITHKLINE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; HEPATITIS B VACCINE;

DISEASE TRANSMISSION; FEMALE; HEALTH CARE PLANNING; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION CONTROL; NEWBORN; ORGANIZATION AND MANAGEMENT; PHILIPPINES; PREGNANCY; PREGNANCY COMPLICATION; PREVENTIVE HEALTH SERVICE; REVIEW; VERTICAL TRANSMISSION;

BCG VACCINE; COMMUNICABLE DISEASE CONTROL; FEMALE; HEALTH PRIORITIES; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PHILIPPINES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 70349795985     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Andre FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994; 44: 144-51.
2. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP) : Recommended childhood immunization schedule - United States, 2002. MMWR 2002; 51: 31-3.
3. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) ; Part 1: Immunization of infants, children and adolescents. MMWR 2005; 54: 1-23.
4. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) ; Part II: Immunization of adults. MMWR 2006; 55: 1-33.
5. Clements CJ, Yang B, Crouch A, et al. Progress in the control of hepatitis B infection in the Western Pacific Region. Vaccine 2005; 24: 1975-82.
6. Creati M, Saleh A, Ruff TA, et al. Implementing the birth dose of hepatitis B vaccine in rural Indonesia. Vaccine 2007; 25: 5985-93.
7. Department of Health, Republic of the Philippines. Administrative Order No. 2006-0015. Implementing guidelines on hepatitis B immunization for infants. Manila: Department of Health, 2006.
8. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34: 1329-39.
9. Goudeau A, Lo KJ, Coursaget P, et al. Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passiveactive immunization. Dev Biol Stand 1983; 54: 399-44.
10. Hipgrave DB, Maynard JE, Biggs BA. Improving birth dose coverage of hepatitis B vaccine. Bull World Health Organ 2006; 84: 65-71.
11. Lansang MAD. Epidemiology and control of hepatitis B infection: a perspective from the Philippines, Asia. Gut 1996; 38: S43-7.
12. Lauderdale DS, Oram RJ, Goldstein KP, Daum RS. Hepatitis B vaccination among children in inner-city public housing, 1991-7. JAMA 1999; 282: 1725-30.
13. Lee SD, Lo KJ, Wu JC, et al. Prevention of maternal-infant hepatitis B transmission by immunization: the role of serum hepatitis b virus DNA. Hepatology 1986; 6: 369-73.
14. Levin CE, Nelson CM, Widjaya A, Moniaga V, Anwar C. The costs of home delivery of a birth dose of hepatitis B vaccine in a prefilled syringe in Indonesia. Bull World Health Organ 2005; 83: 456-61.
15. Lo KJ, Tsai YT, Lee SD, et al. Immunoprophylaxis of infection with hepatitis B virus in infants born to hepatitis B surface antigen-positive carrier mothers. J Infect Dis 1985; 152: 817-22.
16. Luman ET, Fiore AE, Strine TW, Barker LE. Impact of thiomersal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage. JAMA 2004; 291: 2351-8.
17. Mahoney FA, Woodruff B, Auerbach S, et al. Progress on the elimination of hepatitis B virus transmission in Micronesia and American Samoa. Pacific Health Dialog 1996; 3: 140-6.
18. Marion SA, Tomm Pastore M, Pi DW, Mathias RG. Long-term follow-up of hepatitis B vaccine in infants of carrier mothers. Am J Epidemiol 1994; 140: 734-46.
19. Martines J, Paul VK, Bhutta ZA, et al. Neonatal survival: a call for action. Lancet 2005; 365: 1189-97.
20. th ed. Orlando, USA: B Saunders, 2003: 299-337.
21. Monna T, Kuroki T, Oka H, et al. Prevention of vertical transmission of HBV by administration of hepatitis B vaccine combined with HBIG and long-term follow-up of HBsAb titer. Osaka City Med J 1988; 34: 9-17.
22. National Health and Medical Research Council (NHMRC). Australian Immunization Handbook. Canberra: Australian Government Publishing Service, 2003: 145-59.
23. National Statistics Office (NSO) and ORC Macro. Philippines National Demographic and Health Survey 2003. Manila: NSO and ORC Macro, 2004: 125-35.
24. Oman KM, Carnie J, Ruff TA. Hepatitis B immunization coverage of infants born to chronic carrier mothers in Victoria. Aust NZ J Public Health 1997; 21: 731-4.
25. Ota M O C, Vekemans J, Schlegel-Haueter SE, et al. Influence of Mycobacterium bovis Bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol 2002; 168: 919-25.
26. Otto BF, Suarnawa IM, Stewart T, et al. At-birth immunization against hepatitis B using a novel pre-filled immunization device stored outside the cold chain. Vaccine 1999; 18: 498-502.
27. Philhealth Circular. Manila: PhilHealth Newborn Care Package, 2006; 34 s.
28. Philippine National Immunization Conference. Bridging the generation gap in vaccines. Manila, Philippines, 10-11 November 2005.
29. Pichichero ME, Blatter MM, Reisinger KS, et al. Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination. Pediatr Infect Dis J 2002; 21: 854-9.
30. Quiroga R, Halkyer P, Gil F, Nelson C, Kristensen D. A pre-filled injection device for outreach tetanus immunization by Bolivian traditional birth attendants. Rev Panam Salud Publica J Pan Am J Public Health 1998; 4: 20-5.
31. Resti M, Azzari C, Rossi ME, Adami Lami C; Tucci F, Vierucci A. Five-year follow-up of vaccination against hepatitis B virus in newborns vaccinated with a reduced number of doses. Vaccine 1991; 9: 15-18.
32. Ruff TA, Gertig DM, Otto BF, et al. Lombok hepatitis B model immunization project: towards universal infant hepatitis B immunization in Indonesia. J Infect Dis 1995; 171: 290-6.
33. Ruff TA. Immunization strategies for viral diseases in developing countries. Rev Med Virol 1999; 9: 121-38.
34. Schalm SW, Mazel JA, de Gast GC, et al. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with Hepatitis B surface antigen. Pediatrics 1989; 83: 1041-8.
35. Sutanto A, Suarnawa IM, Nelson CM, Stewart T, Soewarso TI. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with a pre-filled, single-use injection device. Bull World Health Organ 1999; 77: 119-25.
36. World Health Assembly. Resolution WHA 45.17. Immunization and vaccine quality. Geneva: World Health Assembly, 1992.
37. World Health Organization. Introduction of hepatitis B vaccine into childhood immunization services. WHO/V&B/01.31. 2001: 7-9.
38. World Health Organization Western Pacific Region. Regional plan to improve hepatitis B control through immunization. Manila: WHO Western Pacific Region, 2003.
39. World Health Organization. Hepatitis B vaccines. WHO position paper. Weekly Epidemiol Rec 2004; 79: 253-64.
40. World Health Organization, Regional Committee for the Western Pacific. Resolution: Measles elimination, hepatitis B control and poliomyelitis eradication. Manila: WHO Western Pacific Region. WPR/RC56. R8. 2005.
41. World Health Organization Western Pacific Regional Office. Preventing mother-to-child transmission of hepatitis B. Operational field guidelines for delivery of the birth dose of hepatitis B vaccine. Manila; WHO Western Pacific Region, 2006a.
42. World Health Organization. Global immunization coverage. 12 October 2006b. [Cited 2007 Feb. 25]. Available from: URL: http://www.who.int/ immunzation-monitoring/data/en/
43. World Health Organization Western Pacific Regional Office. Western Pacific Country health information profiles. 2006 revision. Manila: WHO Western Pacific Region, 2006c: 264-77.
44. World Health Organization. Injection safety. Factsheet No. 231. Geneva: WHO; Revised October 2006d. [Cited 2007 Jul. 15]. Available from: URL: www.who.int/mediacentre/factsheets/fs231/en/
45. World Health Organization Western Pacific Regional Office. Western Pacific regional plan for hepatitis B control through immunization. Draft revised version. Manila: WHO Western Pacific Region, (WP)/ICP/EPI/5.2/001-E. 2007a.
46. World Health Organization 2007b. Philippines reported immunization coverage. [Cited 2007 Jul. 16]. Available from: URL: www.who.int/immunization- monitoring/en/globalsummary/timeseries/tscoveragebycountry.cfm?country= Philippines
47. Yusuf HR, Daniels D, Smith P, Coronado V, Rodewald L. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4: 3: 1: 3 vaccine series. JAMA 2000; 284: 978-83.